Stephen Feider, Chief Financial Officer at Beta Bionics, Inc. (BBNX), sold 10,000 shares at $17.05 ($170K) on 2026-06-26, disclosed to the SEC on 2026-06-30.
Scheduled sale ($170k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $17.05 | 5,104 | $87K | 51.1% |
| 2 | $17.03 | 4,896 | $83K | 48.9% |
| Total | $17.04 avg | 10,000 | $170K | 100% |
| Filing → |
| BBNX | SELL | 2026-03-03 | $18K | — | Filing → |
| BBNX | SELL | 2026-01-05 | $591K | — | Filing → |
| BBNX | SELL | 2025-12-04 | $42K | — | Filing → |